526.37 USD
↗ 3.11 (0.59%)LIVE (AS OF 02:42 PM EDT)
Madrigal Pharmaceuticals, Inc. Common Stock
MDGLNASDAQ • USD
Market: OPEN
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is currently trading at $526.37. The technical outlook is "Sell" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Sep 15, 2026.
Open?$523.00
High?$530.04
Low?$517.48
Prev. Close?$523.26
Volume?128.5K
Avg. Volume?252.2K
VWAP?$524.26
Rel. Volume?0.51x
Bid / Ask
Bid?$526.00 × 80
Ask?$552.30 × 40
Spread?$26.30
Midpoint?$539.15
Valuation & Ratios
Market Cap?12.1B
Shares Out?23.1M
Float?16.5M
Float %?71.7%
P/E Ratio?N/A
P/B Ratio?23.08
EPS?-$14.07
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Employees
915
Market Cap
12.1B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2007-02-06
Address
1001 CONSHOHOCKEN STATE ROAD
WEST CONSHOHOCKEN, PA
Phone: (267) 824-2827
WEST CONSHOHOCKEN, PA
Phone: (267) 824-2827
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?100
Momentum?62
Short Sent.?29
Piotroski F-Score?1/9Weak
Altman Z-Score?8.51Safe
Confidence?58%Low
Short InterestHigh
Short % of Float?13.55%High
Short Interest?2.2M
Days to Cover?9.5
Free Float16.5M
Avg Daily Volume236.7K
Settlement Date2026-08-31
Financial Health
Current Ratio?3.20Strong
Quick Ratio?2.94Strong
Cash Ratio?0.78Adequate
Debt/Equity?0.65Moderate
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?23.08HIGH▾
Peers100
S&P3
P/S?9.42HIGH▾
Peers100
S&P9
P/FCF?N/A▾
EV/EBITDA?-37.8CHEAP▾
S&P97
EV/Sales?9.45HIGH▾
Peers100
S&P12
Returns & Efficiency
ROE?-62.1%WEAK▾
S&P3
ROA?-26.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-206285000
Enterprise Value?$12.1B
Fundamentals ratios updated end of day